Letters to Prescribers
- Second-Generation Antipsychotic Letter—March 2013 (Update)
- Atypical Antipsychotic Letter—May 2012 (Update)
- Atypical Antipsychotic Letter—April 2012 (Update)
See also the Second-Generation (Atypical) Antipsychotic Letter—May 2012
- Atypical Antipsychotic Letter—April 2011 (Update) file size 1MB
- Major Depression and Medications—April 2011 file size 1MB
- Atypical Antipsychotic Letter—January 2010 (Update)
- Seroquel Letter—January 2010 (Update)
- Atypical Antipsychotic Letter—April 2009 file size 11MB
- Invega Letter—November 2009 file size 1MB
Cost and Utilization Data
- Antipsychotic drug cost and utilization data
file size 3MB
- Cost and Utilization of Antipsychotic Drugs (September 2014)
- Utilization of Antipsychotic Drugs (October 2013-September 2014)
- Invega Claims by Dosage Forms (October 2013-September 2014)
- Abilify Claims by Dosage Forms (October 2013- September 2014)
- Risperdal Claims by Dosage Forms (October 2013- September 2014)
Prior Authorization Form for Pharmacy Services
Therapeutic Class Table
This information is provided by MassHealth
People also viewed...
You recently viewed...
Personalization is OFF. Your personal browsing history at Mass.gov is not visible because your personalization is turned off. To view your history, turn your personalization on.
Learn more on our .
*Recommendations are based on site visitor traffic patterns and are not endorsements of that content.